Middle East And Africa BCG Vaccine Market By Demographics (Paediatrics (0-18 Years), Adults (19-35 Years)), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

Middle East And Africa BCG Vaccine Market By Demographics (Paediatrics (0-18 Years), Adults (19-35 Years)), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

ID: 5212 | Pages: 145 | December 2017 | Region: Middle East and Africa


The Middle East and Africa BCG Vaccine market size was around USD XX million in 2017. It is expected to grow at a CAGR of 4.42% to reach USD XX million by 2022. It captures 8% of the global market share.

BCG vaccine stands for Bacillus Calmette-Gurin (BCG) vaccine. It prevents TB and is the only vaccine in the market which could do that. A single dose is given to an infant soon after birth in countries with high occurrence of TB. In countries which TB is not a common occurrence only high risk infants are treated with it. Adults are only treated with this vaccine if their exposure to drug-resistant TB is a regular occurrence.

Increasing number of cases of TB all over the world particularly in the developing countries of APAC, rapid advancements in technology in the field of medical research on vaccines, and savoury government policies and initiatives with improved funding are driving the growth of this market.

Adverse side-effects of this vaccine and supply bottlenecks all around the world are expected to hinder market growth in the forecast period.

The market segmentation is very broad and is only classified by demographics into Paediatrics (0-18 years), and Adults (19-35 years).   Paediatrics is a clear market leader accounting for more than three quarters of market share and is likely to gain even more in the forecast period. It is because BCG vaccination has become mandatory in most of the countries as part of the national immunization program. Moreover, the efficacy of the vaccine is reduced if it is not administered in infancy. The usage of this vaccine is highest in Kenya. Polio and hepatitis B vaccines are usually administered alongside it.

Classification by geography entails Middle East and Africa. It is the least unattractive market.

Key players in the market include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory. Other players in the market include China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institute.

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods                          

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Demographics                          

                              5.1.1 Introduction           

                              5.1.2 Pediatrics (0-18 years)        

                              5.1.3 Adults (19-35 years)            

                              5.1.4 Y-o-Y Growth Analysis, By Demographics   

                              5.1.5 Market Attractiveness Analysis, By Demographics  

                              5.1.6 Market Share Analysis, By Demographics   

               5.2 Product Type                            

                              5.2.1 BCG Vaccine Market           

                              5.2.2 Immune BCG         

                              5.2.3 Therapy BCG          

                              5.2.4 Y-o-Y Growth Analysis, By Product Type     

                              5.2.5 Market Attractiveness Analysis, By Product Type    

                              5.2.6 Market Share Analysis, By Product Type     

               5.3 End User                     

                              5.3.1 Pediatrics 

                              5.3.2 Adults       

                              5.3.4 Y-o-Y Growth Analysis, By End User             

                              5.3.5 Market Attractiveness Analysis, By End User            

                              5.3.6 Market Share Analysis, By End User             

               5.4 Applications               

                              5.4.1 Home        

                              5.4.2 Commercial            

                              5.4.4 Y-o-Y Growth Analysis, By Applications       

                              5.4.5 Market Attractiveness Analysis, By Applications     

                              5.4.6 Market Share Analysis, By Applications       

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Demographics

                                             6.1.3.3 By Product Type

                                             6.1.3.4 By End User

                                             6.1.3.5 By Applications

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Demographics

                                             6.1.4.3 By Product Type

                                             6.1.4.4 By End User

                                             6.1.4.5 By Applications

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Demographics

                                             6.1.5.3 By Product Type

                                             6.1.5.4 By End User

                                             6.1.5.5 By Applications

               6.2 Middle-East                              

               6.3 Africa                          

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Merck & Co., Inc.                    

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Sanofi Pasteur                          

               8.3 Japan BCG Laboratory                          

               8.4 China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation)                     

               8.5 Serum Institute of India Pvt. Ltd.                      

               8.6 InterVax Ltd.                            

               8.7 GreenSignal Bio Pharma Limited (GSBPL)                      

               8.8 Statens Serum Institute                        

9. Competitive Landscape                                         

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East and Africa BCG Vaccine Market By Demographics, From 2016-2022 ( USD Million )
  2. Middle East and Africa Pediatrics (0-18 years) Market By Region, From 2016-2022 ( USD Million )
  3. Middle East and Africa Adults (19-35 years) Market By Region, From 2016-2022 ( USD Million )
  4. Middle East BCG Vaccine Market By Demographics, From 2016-2022 ( USD Million )
  5. Africa BCG Vaccine Market By Demographics, From 2016-2022 ( USD Million )
Middle East And Africa Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequen...
Latin America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Asia-pacific Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targ...
Europe Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted G...
North America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted Gene Seq...
Middle East And Africa Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Global Indu...
Latin America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Asia-Pacific Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Si...
Europe Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Size, Sh...
North America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Global Industry Analysis, Size, Sh...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.